DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Tsourdi E, Zillikens MC, Meier C. et al.
Fracture risk and management of discontinuation of denosumab therapy: A
systematic review and position statement by ECTS.
J Clin Endocrinol Metab 2020;
DOI: 10.1210/clinem/dgaa756. Online ahead of print
We do not assume any responsibility for the contents of the web pages of other providers.